COMMUNIQUÉS West-GlobeNewswire

-
GENFIT : issue positive du DSMB suite à la revue planifiée à 24 mois des données de tolérance et de sécurité d'emploi d'elafibranor, dans l'étude clinique de Phase 3 RESOLVE-IT
23/04/2018 -
Lysogene Strengthens Board of Directors with Appointment of Dr. Peter Lichtlen
23/04/2018 -
Sensorion and Uconn Health Announce Identification of First Potential Biomarker for Noise-Induced Hearing Loss
23/04/2018 -
Sensorion’s SENS-401 Reduces Hearing Loss in Preclinical Study When Oral Administration Initiated Up to Four Days after Acoustic Trauma
23/04/2018 -
Kiadis Pharma N.V notice of Annual General Meeting of shareholders
23/04/2018 -
Curetis to Publish its 2017 Annual Results on April 30, 2018
23/04/2018 -
Akcea Therapeutics to Present Data on Inotersen for the Treatment of hATTR Amyloidosis at the 2018 American Academy of Neurology Annual Meeting
21/04/2018 -
Accelerate Diagnostics announces sizeable release of new data at ECCMID 2018
21/04/2018 -
Caelum Biosciences Submits Draft Registration Statement on Form S-1 to the Securities and Exchange Commission
21/04/2018 -
Pacific Biosciences of California, Inc. First Quarter 2018 Financial Results Call
21/04/2018 -
Orion to sell its Orion Diagnostica division - Due to the transaction Orion updates its outlook
21/04/2018 -
Bellicum Pharmaceuticals Announces Closing of Public Offering
20/04/2018 -
Kalytera Announces Next Payment in Shares under Services Agreement with Salzman Group
20/04/2018 -
Marrone Bio Innovations Announces Closing of $12 Million Public Offering of Common Stock
20/04/2018 -
Shire plc : Statement re Proposal from Takeda Pharmaceutical Company Limited
20/04/2018 -
Sienna Announces 2018 Annual and Special Meeting
20/04/2018 -
IBA SA : data concerning transparency
20/04/2018 -
IBA SA : Information en matière de transparence
20/04/2018 -
LifePoint Health To Broadcast Its First Quarter 2018 Conference Call Live On The Internet
20/04/2018
Pages